
|Articles|November 11, 2007
Accommodating lens model continues trend of improved outcomes throughout implant evolution
A fourth-generation version of an accommodating IOL (HD-100 crystalens, eyeonics) provides excellent uncorrected visual acuity (UCVA) at all distances without degrading contrast acuity, according to the results of an FDA multicenter clinical trial.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
IGS 2026: Clinical pearls for detecting pre-perimetric glaucoma
2
IGS 2026: The expanding role of artificial intelligence in ophthalmology
3
Broadening horizons: Expanding your surgical portfolio with SMILE pro for Hyperopia
4
Study finds artificial tear viscosity and shear-thinning behavior vary by formulation
5




























